Bermele plc is a special purpose acquisition company formed to acquire realisable and/or developed commercial technologies focused in the Life Science, Pharmaceutical and Biotechnology sector.

The Company has been formed for the purpose of acquiring a business or businesses operating in the pharmaceutical and biotechnology sectors. The Company does not have any specific acquisition under consideration at present and does not expect to engage in substantive negotiations with any target company or business until after Admission.

The Acquisition, of either the assets, or the share capital, of a target company, will be treated as a Reverse Takeover and in order to maintain its listing the enlarged group would be required to apply to have its shares readmitted to the Official List and trading on the Main Market of the London Stock Exchange.

The Company’s determinations in identifying a prospective target company or acquisition in the pharmaceutical and biotechnology sectors will not be limited to a specific geographic region.